{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T19:52:07Z","timestamp":1771357927895,"version":"3.50.1"},"reference-count":28,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales Pharmaceutiques Fran\u00e7aises"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.pharma.2019.04.004","type":"journal-article","created":{"date-parts":[[2019,5,25]],"date-time":"2019-05-25T16:10:12Z","timestamp":1558800612000},"page":"382-393","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Application of HPTLC, spectrofluorimetry and differential pulse voltammetry for determination of the antifungal drug posaconazole in suspension dosage form"],"prefix":"10.1016","volume":"77","author":[{"given":"H.A.","family":"Khalil","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.F.","family":"El-Yazbi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.A.","family":"Hamdy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.S.","family":"Belal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"S1","key":"10.1016\/j.pharma.2019.04.004_bib0145","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1439-0507.2006.01295.x","article-title":"A new, broad-spectrum azole antifungal: posaconazole \u2013 mechanisms of action and resistance, spectrum of activity","volume":"49","author":"Hof","year":"2006","journal-title":"Mycoses"},{"issue":"S1","key":"10.1016\/j.pharma.2019.04.004_bib0150","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1439-0507.2006.01297.x","article-title":"HPLC analysis of the antifungal agent posaconazole in patients with haematological diseases","volume":"49","author":"M\u00fcller","year":"2006","journal-title":"Mycoses"},{"issue":"12","key":"10.1016\/j.pharma.2019.04.004_bib0155","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1515\/CCLM.2008.338","article-title":"Development and validation of a high-performance liquid chromatography assay for posaconazole utilizing solid-phase extraction","volume":"46","author":"St\u00f6rzinger","year":"2008","journal-title":"Clin Chem Lab Med"},{"issue":"12","key":"10.1016\/j.pharma.2019.04.004_bib0160","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1111\/j.1469-0691.2011.03732.x","article-title":"HPLC\/UV or bioassay: two valid methods for posaconazole quantification in human serum samples","volume":"18","author":"Cendejas-Bueno","year":"2012","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"10.1016\/j.pharma.2019.04.004_bib0165","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.jchromb.2007.01.021","article-title":"Simultaneous quantification of voriconazole and posaconazole in human plasma by high-performance liquid chromatography with ultra-violet detection","volume":"852","author":"Chhun","year":"2007","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"issue":"5","key":"10.1016\/j.pharma.2019.04.004_bib0170","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/j.jpba.2009.06.030","article-title":"Simultaneous determination of five systemic azoles in plasma by high-performance liquid chromatography with ultraviolet detection","volume":"50","author":"Gordien","year":"2009","journal-title":"J Pharm Biomed Anal"},{"issue":"1","key":"10.1016\/j.pharma.2019.04.004_bib0175","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1128\/AAC.00768-12","article-title":"A simple high-performance liquid chromatography method for simultaneous determination of three triazole antifungals in human plasma","volume":"57","author":"Zhang","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"10.1016\/j.pharma.2019.04.004_bib0180","doi-asserted-by":"crossref","first-page":"317","DOI":"10.3797\/scipharm.1111-11","article-title":"Stability-indicating HPLC method for posaconazole bulk assay","volume":"80","author":"Garcia","year":"2012","journal-title":"Sci Pharm"},{"issue":"24","key":"10.1016\/j.pharma.2019.04.004_bib0185","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1016\/j.jchromb.2009.06.022","article-title":"Determination of the antifungal agent posaconazole in human serum by HPLC with parallel column-switching technique","volume":"877","author":"Neubauer","year":"2009","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"issue":"6","key":"10.1016\/j.pharma.2019.04.004_bib0190","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1097\/FTD.0b013e3182381bb1","article-title":"Measurement of posaconazole, itraconazole, and hydroxyitraconazole in plasma\/serum by high-performance liquid chromatography with fluorescence detection","volume":"33","author":"Buckner","year":"2011","journal-title":"Ther Drug Monit"},{"issue":"1","key":"10.1016\/j.pharma.2019.04.004_bib0195","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.jpba.2006.06.011","article-title":"A sensitive liquid chromatography and mass spectrometry method for the determination of posaconazole in human plasma","volume":"43","author":"Shen","year":"2007","journal-title":"J Pharm Biomed Anal"},{"issue":"5","key":"10.1016\/j.pharma.2019.04.004_bib0200","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1515\/CCLM.2009.129","article-title":"A routine method for the quantification of the novel antimycotic drug posaconazole in plasma using liquid chromatography-tandem mass spectrometry","volume":"47","author":"Vogeser","year":"2009","journal-title":"Clin Chem Lab Med"},{"issue":"1","key":"10.1016\/j.pharma.2019.04.004_bib0205","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jpba.2009.03.034","article-title":"A high-throughput LC \u2013 MS\/MS method for the quantitation of posaconazole in human plasma: implementing fused core silica liquid chromatography","volume":"50","author":"Cunliffe","year":"2009","journal-title":"J Pharm Biomed Anal"},{"key":"10.1016\/j.pharma.2019.04.004_bib0210","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.cca.2015.08.023","article-title":"Determination of posaconazole concentration with LC-MS\/MS in adult patients with hematologic malignancy","volume":"450","author":"Chae","year":"2015","journal-title":"Clin Chim Acta"},{"issue":"1","key":"10.1016\/j.pharma.2019.04.004_bib0215","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jchromb.2009.11.017","article-title":"Method for therapeutic drug monitoring of azole antifungal drugs in human serum using LC\/MS\/MS","volume":"878","author":"Alffenaar","year":"2010","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"issue":"4","key":"10.1016\/j.pharma.2019.04.004_bib0220","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1097\/FTD.0b013e3181e185fd","article-title":"Validated liquid chromatography \u2013 tandem mass spectroscopy method for the simultaneous quantification of four antimycotic agents in human serum","volume":"32","author":"Chahbouni","year":"2010","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.pharma.2019.04.004_bib0225","first-page":"919","article-title":"Simultaneous quantitation of azole antifungals, antibiotics, imatinib, and raltegravir in human plasma by two-dimensional high-performance liquid chromatography-tandem mass spectrometry","author":"Jourdil","year":"2013","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"10.1016\/j.pharma.2019.04.004_bib0230","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.cca.2017.08.032","article-title":"Development and validation of a liquid chromatography-tandem mass spectrometry assay for the simultaneous quantitation of 5 azole antifungals and 1 active metabolite","volume":"474","author":"McShane","year":"2017","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.pharma.2019.04.004_bib0235","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.chroma.2011.08.012","article-title":"Rapid and sensitive determination of posaconazole in patient plasma by capillary electrophoresis with field-amplified sample stacking","volume":"1226","author":"Liao","year":"2012","journal-title":"J Chromatogr A"},{"issue":"1","key":"10.1016\/j.pharma.2019.04.004_bib0240","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s00216-012-6087-3","article-title":"Simultaneous determination of triazole antifungal drugs in human plasma by sweeping-micellar electrokinetic chromatography","volume":"404","author":"Lin","year":"2012","journal-title":"Anal Bioanal Chem"},{"issue":"3","key":"10.1016\/j.pharma.2019.04.004_bib0245","doi-asserted-by":"crossref","first-page":"247","DOI":"10.12923\/j.2084-980X\/26.3\/a.01","article-title":"hotostability of triazole antifungal drugs in the solid state","volume":"26","author":"Ekiert","year":"2013","journal-title":"Curr Issues Pharm Med Sci"},{"issue":"3","key":"10.1016\/j.pharma.2019.04.004_bib0250","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1002\/elan.201600621","article-title":"A Disposable Carbon Nanotubes-screen Printed Electrode (CNTs-SPE) for Determination of the antifungal agent posaconazole in biological samples","volume":"29","author":"Hassan","year":"2017","journal-title":"Electroanal"},{"issue":"9","key":"10.1016\/j.pharma.2019.04.004_bib0255","first-page":"6573","article-title":"Spectrophotometric and fluorimetric determination of posaconazole in dosage form and spiked human plasma","volume":"6","author":"Sultan","year":"2016","journal-title":"Indo Am J Pharm Res"},{"key":"10.1016\/j.pharma.2019.04.004_bib0260","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/241035","article-title":"A comparative study of newly developed HPLC-DAD and UHPLC-UV assays for the determination of posaconazole in bulk powder and suspension dosage form","author":"Hamdy","year":"2014","journal-title":"J Anal Methods Chem"},{"key":"10.1016\/j.pharma.2019.04.004_bib0265","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.ejps.2016.05.009","article-title":"The effect of hyperlipidemia on the pharmacokinetics, hepatic and pulmonary uptake of posaconazole in rat","volume":"91","author":"Khalil","year":"2016","journal-title":"Eur J Pharm Sci"},{"issue":"12","key":"10.1016\/j.pharma.2019.04.004_bib0270","first-page":"987","article-title":"Differential pulse polarographic investigation of the antifungal drugs itraconazole, ketoconazole, fluconazole and voriconazole using a dropping mercury electrode","volume":"67","author":"Knoth","year":"2012","journal-title":"Die Pharmazie"},{"key":"10.1016\/j.pharma.2019.04.004_bib0275","series-title":"Validation of analytical procedures: Text and methodology, Q2 (R1), International Conference on Harmonisation","author":"ICH","year":"2005"},{"issue":"6","key":"10.1016\/j.pharma.2019.04.004_bib0280","first-page":"374","article-title":"Electrochemical behavior of the antifungal agents itraconazole, posaconazole and ketoconazole at a glassy carbon electrode","volume":"70","author":"Knoth","year":"2015","journal-title":"Die Pharmazie"}],"container-title":["Annales Pharmaceutiques Fran\u00e7aises"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003450918302190?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003450918302190?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T23:34:17Z","timestamp":1757720057000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003450918302190"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":28,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["S0003450918302190"],"URL":"https:\/\/doi.org\/10.1016\/j.pharma.2019.04.004","relation":{},"ISSN":["0003-4509"],"issn-type":[{"value":"0003-4509","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Application of HPTLC, spectrofluorimetry and differential pulse voltammetry for determination of the antifungal drug posaconazole in suspension dosage form","name":"articletitle","label":"Article Title"},{"value":"Annales Pharmaceutiques Fran\u00e7aises","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharma.2019.04.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Acad\u00e9mie Nationale de Pharmacie. Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}